JavaScript è disabilitato. La navigazione principale e le pagine editoriali restano disponibili, ma i widget di mercato in tempo reale, i grafici, la ricerca e le funzioni di personalizzazione potrebbero essere limitati.

Will the Kernel Flow 2 be used for a neuroimaging study of sex on psychedelics by EOY2027?

Health & MedicineOne-Off1a

Manifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibrato

Previsione della comunità attuale

Sì 54.8%

Previsori

1

Tipo di domanda

binary

Metodologia

Play-money forecasting platform

Tipo di fonte

Previsione

Dati di mercato

Aggiornato 14 ore fa

Obsoleto

10 apr 26, 21:24 UTC31 dic 27, 23:59 UTC

Trend

Esito24hProbabilità

Mercati Correlati

Domande correlate per il contesto, non un confronto tra contratti equivalenti.

Will the OPM-MEG be used for a neuroimaging study of sex on psychedelics by EOY2027?

Manifold Markets

Will NeuroField Neurotherapy use a kernel flow helmet by EOY2028?

Manifold Markets

Will Washington state decriminalize ALL psychedelics by 2026?

Manifold Markets

Hantavirus pandemic in 2026?

Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?

FDA approves skin cancer vaccine by which date?

Regole

Resolution criteria

This market resolves to YES if there is public evidence (e.g., a peer-reviewed publication, a press release from a reputable academic or clinical institution, or a clinical trial registry entry on ClinicalTrials.gov) confirming that a study using the Kernel Flow 2 neuroimaging system specifically to investigate the neurological effects of sex on psychedelics has commenced or has been conducted by December 31, 2027.
If no such evidence is publicly available by the resolution date, the market resolves to NO.
Kernel Flow 2 is a non-invasive, portable neuroimaging headset that utilizes time-domain functional near-infrared spectroscopy (TD-fNIRS) and electroencephalography (EEG) to measure brain activity.
Launched in 2023, the system is designed to provide fMRI-like functional data, making it suitable for research settings in fields such as cognitive health, depression, and neurodegenerative disease.
Kernel has previously validated its earlier Flow technology in studies measuring the impact of psychoactive substances on brain activity.

Mercati aperti

Health & Medicine

Hantavirus pandemic in 2026?

No-0.1pt97%
Yes+0.1pt3%

Volume totale: 15,6 Mln €
Volume 24h: 18,3K €

Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?

No96%
Yes+1.9pt4%

Volume totale: 1,6 Mln €
Volume 24h: 5,2K €

When will Intellia Therapeutics submit a BLA for Lonvo-z?

before October+64.0pt98%
before 2027+22.0pt98%
before December+30.0pt98%

+3 altri esiti

FDA approves skin cancer vaccine by which date?

December 31,+6.0pt65%
September+2.0pt41%
June28%

Volume totale

New pandemic in 2026?

No+0.5pt94%
Yes-0.5pt6%

Volume totale: 916K €
Volume 24h: 1,5K €

Measles cases in 2026?

Above 300099%
Above 400097%
Above 6000-2.0pt57%

+2 altri esiti

Volume totale: 863,6K €
Volume 24h: 1K €

Domande frequenti

Quali sono le probabilità attuali per Will the Kernel Flow 2 be used for a neuroimaging study of sex on psychedelics by EOY2027??: Manifold Markets quota Yes al 55% al 8 settembre 2026.
Quando si risolve Will the Kernel Flow 2 be used for a neuroimaging study of sex on psychedelics by EOY2027??: Will the Kernel Flow 2 be used for a neuroimaging study of sex on psychedelics by EOY2027? dovrebbe risolversi il 31 dicembre 2027.
Come viene liquidato Will the Kernel Flow 2 be used for a neuroimaging study of sex on psychedelics by EOY2027??: Manifold Markets liquida questo mercato come segue: Resolution criteria

Segnala un problema di dati su questo mercato